PRQR compared with EQ: revenue, margins and what each company keeps, and the suppliers and customers both name

PRQRProQR Therapeutics N.V.

Mkt capRevenueRevenue

EQEquillium, Inc.

Mkt capRevenueRevenue

Compare

PRQRProQR Therapeutics N.V.

EQEquillium, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

PRQRProQR Therapeutics N.V.

1.38▼−4.31%· post 1.43

Mkt cap$146.5MRevenue—Revenue—

EQEquillium, Inc.

1.38▼−2.90%· post 1.38

ClosedOct 30 '26

Mkt cap$86.9MRevenue$4MQ4 FY24Revenue$41MFY24

Compare

ClosedOct 30 '26

PRQRProQR Therapeutics N.V.

EQEquillium, Inc.

1.38▼−4.31%post 1.43

Price

1.38▼−2.90%post 1.38

$146.5M

Mkt cap

$86.9M

—

Revenue

$4MQ4 FY24

—

Revenue

$41MFY24

PRQR1.38▼−4.31%vsEQ1.38▼−2.90%ClosedOct 30 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

PRQR, solidEQ, dashed

Supply-chain overlap

Revenue flow

PRQR: latest quarter not drawable. EQ: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only PRQR 1

LLYEli Lillycustomer

Shared 0

No shared counterparties.

Only EQ 2

—Bioconunlistedsupplier

—Ono Pharmaceuticalunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR